163 related articles for article (PubMed ID: 23240667)
1. Hereditary gynaecological malignancies: advances in screening and treatment.
Folkins AK; Longacre TA
Histopathology; 2013 Jan; 62(1):2-30. PubMed ID: 23240667
[TBL] [Abstract][Full Text] [Related]
2. Hereditary non-BRCA gynecological tumors.
Vellone VG; Paudice M; Varesco L
Minerva Ginecol; 2016 Oct; 68(5):579-86. PubMed ID: 26930387
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing by cancer site: ovary.
Weissman SM; Weiss SM; Newlin AC
Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
[TBL] [Abstract][Full Text] [Related]
4. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
5. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
6. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
Lu KH
Fam Cancer; 2008; 7(1):53-8. PubMed ID: 17636427
[TBL] [Abstract][Full Text] [Related]
7. [Recommendations for the management of women with an increased genetic risk of gynaecological cancer].
Verheijen RH; Boonstra H; Menko FH; de Graaff J; Vasen HF; Kenter GG
Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2414-8. PubMed ID: 12518519
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2.
Swisher E
Curr Womens Health Rep; 2003 Feb; 3(1):27-32. PubMed ID: 12521547
[TBL] [Abstract][Full Text] [Related]
9. Hereditary ovarian cancer.
Prat J; Ribé A; Gallardo A
Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
[TBL] [Abstract][Full Text] [Related]
10. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
[TBL] [Abstract][Full Text] [Related]
11. Screening and prevention of hereditary gynecologic cancers.
Kehoe SM; Kauff ND
Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
[TBL] [Abstract][Full Text] [Related]
12. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
Shulman LP
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
[TBL] [Abstract][Full Text] [Related]
13. [Hereditary predispositions to gynaecological cancers].
Coupier I; Pujol P
Gynecol Obstet Fertil; 2005 Nov; 33(11):851-6. PubMed ID: 16256400
[TBL] [Abstract][Full Text] [Related]
14. Genetic testing by cancer site: uterus.
Daniels MS
Cancer J; 2012; 18(4):338-42. PubMed ID: 22846735
[TBL] [Abstract][Full Text] [Related]
15. Current and future role of genetic screening in gynecologic malignancies.
Ring KL; Garcia C; Thomas MH; Modesitt SC
Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
[TBL] [Abstract][Full Text] [Related]
16. Familial breast and ovarian cancers.
Arai M; Utsunomiya J; Miki Y
Int J Clin Oncol; 2004 Aug; 9(4):270-82. PubMed ID: 15375703
[TBL] [Abstract][Full Text] [Related]
17. Advances in the understanding of risk factors for ovarian cancer.
Bandera CA
J Reprod Med; 2005 Jun; 50(6):399-406. PubMed ID: 16050564
[TBL] [Abstract][Full Text] [Related]
18. [Lynch syndrome and gynaecologic's cancer: follow-up recommendations].
Magri K; Millon G
J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):68-71. PubMed ID: 17293255
[TBL] [Abstract][Full Text] [Related]
19. Hereditary ovarian cancer: molecular genetics and clinical implications.
Boyd J; Rubin SC
Gynecol Oncol; 1997 Feb; 64(2):196-206. PubMed ID: 9038264
[TBL] [Abstract][Full Text] [Related]
20. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
